aap Implantate AG (0N5A) Cuts H1 2026 EBITDA Loss by 52% and Reports Record July Orders

aap Implantate AG (0N5A) Cuts H1 2026 EBITDA Loss by 52% and Reports Record July Orders →

aap Implantate AG (0N5A), the Berlin-based medical technology firm specializing in traumatology implants, has released its half-year results for the period ending 30 June 2026, revealing a 52% reduction in group EBITDA loss to EUR -140 thou…